President Donald Trump has disclosed making another 1,000-plus stock transactions in June, continuing an unprecedented pace of trading activity while in office that has drawn scrutiny over his ability to personally profit off of the presidency.
The trades, submitted in a filing to the Office of Government Ethics, included the purchase and sale of thousands of dollars of stock in energy companies directly affected by Trump’s ongoing war in Iran.
The transactions also targeted companies in a wide range of industries that Trump has sought to shape through his policies, including drug manufacturers like Eli Lilly and Merck and major artificial intelligence firms like Nvidia.
The White House has repeatedly denied that Trump has any influence over his investment accounts, insisting that his portfolio is independently managed. A spokesperson did not immediately respond to a request for comment on Trump’s most recently disclosed transactions.
But the size and frequency of his transactions while in office have generated sharp criticism from Democrats and watchdogs, who point to evidence of Trump’s ballooning personal wealth during the first half of his second presidency.
